Aclaris Therapeutics (ACRS) Receivables - Other (2019 - 2021)
Aclaris Therapeutics (ACRS) posted quarterly Receivables - Other of $24000.0 for Q4 2021, down 92.0% year-over-year from $300000.0 in Q4 2020, and little changed quarter-over-quarter from $24000.0 in Q3 2021.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Receivables - Other (2019 - 2021) Analysis & Trends
Aclaris Therapeutics' Receivables - Other history runs 3 years deep, the most recent figure standing at $24000.0 for Q4 2021.
- In Q4 2021, Receivables - Other fell 92.0% year-over-year to $24000.0; the TTM figure through Dec 2021 stood at $24000.0 (down 92.0% YoY), while the FY2021 annual figure was $24000.0, down 92.0% from the prior year.
- Receivables - Other for Q4 2021 stood at $24000.0, roughly flat from $24000.0 in the prior quarter.
- The five-year high for Receivables - Other was $300000.0 in Q2 2020, with the low at $20000.0 in Q1 2021.
- The 3-year median for Receivables - Other is $100000.0 (2019), against an average of $143555.6.
- The sharpest annual moves came in 2020 and 2021: Receivables - Other jumped 200.0% in 2020, then slumped 92.0% in 2021.
- Aclaris Therapeutics' Receivables - Other stood at $100000.0 in 2019, then surged by 200.0% to $300000.0 in 2020, then plunged by 92.0% to $24000.0 in 2021.
- Business Quant data shows ACRS's Receivables - Other at $24000.0 in Q4 2021, $24000.0 in Q3 2021, and $24000.0 in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 10 | Aclaris Therapeutics | 878.55 Mn | 878.55 Mn | 1.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 24,000.00 |
| Sep 30, 2021 | 24,000.00 |
| Jun 30, 2021 | 24,000.00 |
| Mar 31, 2021 | 20,000.00 |
| Dec 31, 2020 | 300,000.00 |
| Sep 30, 2020 | 300,000.00 |
| Jun 30, 2020 | 300,000.00 |
| Mar 31, 2020 | 200,000.00 |
| Dec 31, 2019 | 100,000.00 |
| Sep 30, 2019 | 100,000.00 |